Ocular findings in patients with psoriasis: is it related to the side effects of treatment or to psoriasis itself? A case-control study

Objectives: To assess ocular abnormalities in psoriatic patients (new-cases versus patients under treatment) in comparison with healthy controls. Methods: A total of 200 psoriatic patients and 100 healthy controls were enrolled in this prospective, observational study. The demographic data of the in...

Full description

Bibliographic Details
Main Authors: Fariba Ghalamkarpour, Alireza Baradaran-Rafii, Mohammad Mehdi Sadoughi, Fahimeh Abdollahimajd, Shima Younespour, Omid Zargari, Robert I. Rudolph
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Journal of Dermatological Treatment
Subjects:
Online Access:http://dx.doi.org/10.1080/09546634.2019.1577947
_version_ 1797683690310991872
author Fariba Ghalamkarpour
Alireza Baradaran-Rafii
Mohammad Mehdi Sadoughi
Fahimeh Abdollahimajd
Shima Younespour
Omid Zargari
Robert I. Rudolph
author_facet Fariba Ghalamkarpour
Alireza Baradaran-Rafii
Mohammad Mehdi Sadoughi
Fahimeh Abdollahimajd
Shima Younespour
Omid Zargari
Robert I. Rudolph
author_sort Fariba Ghalamkarpour
collection DOAJ
description Objectives: To assess ocular abnormalities in psoriatic patients (new-cases versus patients under treatment) in comparison with healthy controls. Methods: A total of 200 psoriatic patients and 100 healthy controls were enrolled in this prospective, observational study. The demographic data of the individuals were recorded. Dermatological and ophthalmologic examinations were conducted; ocular surface disease index (OSDI), Schirmer’s and tear break-up time (TBUT) values were also measured. Results: The mean values of TBUT and Schirmer’s tests in patients were significantly lower than the controls and significantly higher scores of OSDI were observed among patients compared to the controls (p < .0001); dry eye disease was more frequent in the patients than the healthy subjects (p = .001). Other ocular findings including cataract and uveitis were not significantly different between the groups. Although no significant differences were found between the ocular findings of new cases and patients under treatment, ocular findings in cases under treatment were associated with the type of treatment and more frequent in those treated with methotrexate, followed by acitretin and biologic drugs. Conclusions: Ocular surface problems in psoriatic patients are more common than previously thought; in addition to the role of treatment modalities, psoriasis itself and a probable systemic inflammation may play an important role.Key Points There are limited case-control studies about ocular manifestations in psoriasis and also its pathogenesis is not yet clear. This study shows that ocular surface problems in psoriatic patients are higher than healthy subjects; in addition to the role of treatment modalities, psoriasis itself and a probable systemic inflammation may play a pivotal role. Regular ophthalmological evaluations are recommended in psoriatic patients especially those with more severe and chronic form of the disease, to prevent any complications.
first_indexed 2024-03-12T00:18:06Z
format Article
id doaj.art-5bdfa1aab41b451b909033975dc1b14a
institution Directory Open Access Journal
issn 0954-6634
1471-1753
language English
last_indexed 2024-03-12T00:18:06Z
publishDate 2020-01-01
publisher Taylor & Francis Group
record_format Article
series Journal of Dermatological Treatment
spelling doaj.art-5bdfa1aab41b451b909033975dc1b14a2023-09-15T14:08:34ZengTaylor & Francis GroupJournal of Dermatological Treatment0954-66341471-17532020-01-01311273210.1080/09546634.2019.15779471577947Ocular findings in patients with psoriasis: is it related to the side effects of treatment or to psoriasis itself? A case-control studyFariba Ghalamkarpour0Alireza Baradaran-Rafii1Mohammad Mehdi Sadoughi2Fahimeh Abdollahimajd3Shima Younespour4Omid Zargari5Robert I. Rudolph6Shahid Beheshti University of Medical SciencesOphthalmic Research Center, Shahid Beheshti University of Medical SciencesOphthalmic Research Center, Shahid Beheshti University of Medical SciencesShahid Beheshti University of Medical SciencesNational Institute of Health Research, Tehran University of Medical SciencesDANA ClinicUniversity of PennsylvaniaObjectives: To assess ocular abnormalities in psoriatic patients (new-cases versus patients under treatment) in comparison with healthy controls. Methods: A total of 200 psoriatic patients and 100 healthy controls were enrolled in this prospective, observational study. The demographic data of the individuals were recorded. Dermatological and ophthalmologic examinations were conducted; ocular surface disease index (OSDI), Schirmer’s and tear break-up time (TBUT) values were also measured. Results: The mean values of TBUT and Schirmer’s tests in patients were significantly lower than the controls and significantly higher scores of OSDI were observed among patients compared to the controls (p < .0001); dry eye disease was more frequent in the patients than the healthy subjects (p = .001). Other ocular findings including cataract and uveitis were not significantly different between the groups. Although no significant differences were found between the ocular findings of new cases and patients under treatment, ocular findings in cases under treatment were associated with the type of treatment and more frequent in those treated with methotrexate, followed by acitretin and biologic drugs. Conclusions: Ocular surface problems in psoriatic patients are more common than previously thought; in addition to the role of treatment modalities, psoriasis itself and a probable systemic inflammation may play an important role.Key Points There are limited case-control studies about ocular manifestations in psoriasis and also its pathogenesis is not yet clear. This study shows that ocular surface problems in psoriatic patients are higher than healthy subjects; in addition to the role of treatment modalities, psoriasis itself and a probable systemic inflammation may play a pivotal role. Regular ophthalmological evaluations are recommended in psoriatic patients especially those with more severe and chronic form of the disease, to prevent any complications.http://dx.doi.org/10.1080/09546634.2019.1577947psoriasistreatmentdry eyeschirmertbutocular surface disease index
spellingShingle Fariba Ghalamkarpour
Alireza Baradaran-Rafii
Mohammad Mehdi Sadoughi
Fahimeh Abdollahimajd
Shima Younespour
Omid Zargari
Robert I. Rudolph
Ocular findings in patients with psoriasis: is it related to the side effects of treatment or to psoriasis itself? A case-control study
Journal of Dermatological Treatment
psoriasis
treatment
dry eye
schirmer
tbut
ocular surface disease index
title Ocular findings in patients with psoriasis: is it related to the side effects of treatment or to psoriasis itself? A case-control study
title_full Ocular findings in patients with psoriasis: is it related to the side effects of treatment or to psoriasis itself? A case-control study
title_fullStr Ocular findings in patients with psoriasis: is it related to the side effects of treatment or to psoriasis itself? A case-control study
title_full_unstemmed Ocular findings in patients with psoriasis: is it related to the side effects of treatment or to psoriasis itself? A case-control study
title_short Ocular findings in patients with psoriasis: is it related to the side effects of treatment or to psoriasis itself? A case-control study
title_sort ocular findings in patients with psoriasis is it related to the side effects of treatment or to psoriasis itself a case control study
topic psoriasis
treatment
dry eye
schirmer
tbut
ocular surface disease index
url http://dx.doi.org/10.1080/09546634.2019.1577947
work_keys_str_mv AT faribaghalamkarpour ocularfindingsinpatientswithpsoriasisisitrelatedtothesideeffectsoftreatmentortopsoriasisitselfacasecontrolstudy
AT alirezabaradaranrafii ocularfindingsinpatientswithpsoriasisisitrelatedtothesideeffectsoftreatmentortopsoriasisitselfacasecontrolstudy
AT mohammadmehdisadoughi ocularfindingsinpatientswithpsoriasisisitrelatedtothesideeffectsoftreatmentortopsoriasisitselfacasecontrolstudy
AT fahimehabdollahimajd ocularfindingsinpatientswithpsoriasisisitrelatedtothesideeffectsoftreatmentortopsoriasisitselfacasecontrolstudy
AT shimayounespour ocularfindingsinpatientswithpsoriasisisitrelatedtothesideeffectsoftreatmentortopsoriasisitselfacasecontrolstudy
AT omidzargari ocularfindingsinpatientswithpsoriasisisitrelatedtothesideeffectsoftreatmentortopsoriasisitselfacasecontrolstudy
AT robertirudolph ocularfindingsinpatientswithpsoriasisisitrelatedtothesideeffectsoftreatmentortopsoriasisitselfacasecontrolstudy